I move amendment No. 2:
In page 3, before section 2, to insert the following new section:
2—(1) A health board shall make available without charge to persons who, in the opinion of the chief executive officer of the board, have contracted hepatitis C directly or indirectly from the use of Human Immunoglobulin-Anti-D or the receipt within the State of another blood product or a blood transfusion and to persons of such other classes (if any) as may be prescribed—
(a) general practitioner medical and surgical services, in relation to all medical conditions, provided by registered medical practitioners (within the meaning of the Medical Practitioners Act, 1978) chosen by the persons,
(b) drugs, medicines and medical and surgical appliances,
(c) the nursing service specified in section 60 of the Act of 1970,
(d) the service specified in section 61 of the Act of 1970,
(e) dental, ophthalmic and aural treatment and dental, optical and aural appliances,
(f) counselling services in respect of hepatitis C, and
(g) such other services as may be prescribed.
(2) In this section ‘the Act of 1970' means the Health Act, 1970.".
This amendment is a new section and replaces section 2 in the Bill. It arose from submissions made to me during the course of consultation and I indicated on Second Stage that the Bill would be amended.
If Members consider the comparative texts, the major change involves the different categories who were infected with hepatitis C from blood or blood products. The Bill as originally published included those who were infected with hepatitis C from the anti-D product and I gave a commitment that those who were infected as a result of blood transfusions would be included by way of regulation. The group representing that category of people, Transfusion Positive — Positive Action represents those infected by the anti-D product — stated that they would rather be included in the Bill than covered under subsequent regulations. The first addition to the text is the phrase "or the receipt within the State of another blood product or a blood transfusion". This explicitly includes them in the section rather than by way of regulation.
The last line of subsection (1) of the amendment refers to "persons of such other classes (if any)". This will provide for any other group we may wish to cover under the Bill. It is a catchall phrase which will permit us to extend the benefits of the Bill to any unforeseen group.
Members argued with me about another issue relevant to the Bill during Question Time in the Dáil. To put it in context, Members will recall that when the tribunal was established in respect of those persons who contracted hepatitis C from a blood transfusion as distinct from the anti-D product, I was asked how this could be proven. This committee debated the issue of the criminal level of proof being beyond reasonable doubt and the civil level of proof being on the balance of probabilities. It was eventually decided that it would be on the balance of probabilities.
People do not want a situation to develop where their health needs would be contingent on their qualifying in court or under the tribunal for compensation. For example, a person who made an application to the tribunal because they were infected by a blood product and had contracted hepatitis C might not be awarded compensation. In such cases it is my intention to provide under the Bill that a more liberal view be taken in deciding who qualifies. Rather than stating that compensation will be available to those who contracted hepatitis C from the anti-D product or a blood transfusion, we are inserting the phrase "in the opinion of the chief executive officer". The chief executive officer will be able to take a more liberal view of the qualification requirements.
It is intended that anyone who became infected with hepatitis C from anti-D or a blood transfusion will automatically qualify for compensation. If there is a doubt and a person infected with the disease cannot produce the evidence necessary for a court of law or the tribunal, the chief executive will have discretion to allow them benefit under this Bill. All those who contracted hepatitis C from a blood product or a blood transfusion will be included and this gives discretion to the chief executive to widen that category further in circumstances where his opinion might be slightly at variance with that of the strict proofs which will be required in the different fora.
Those are the principal differences in the main body of the amendment. In listing the services to be provided, the Bill gave primary status to (a), (b) and (c) and then stated: "In particular, but without prejudice to the generality of subsection (1) (c) of this section, the following services or any one or more of them may be prescribed under that provision:". The Bill as initiated stated: "may be provided". This is now being explicitly provided for and there will be no differentiation between the elements of the list. It strengthens the package and gives a stronger primary statutory right to the benefits from (c) onwards. There are also some textual amendments of a technical nature.
Those are the differences between section 2 in the Bill as initiated and the new section which will replace it by way of amendment. They are designed to give a stronger statutory base to the service being provided. Some of them are in response to the normal screening work one would do in improving a Bill for Committee Stage and others are in direct response to points made by Deputies and groups representing people who want to avail of this Bill.